Møller Morten Hylander, Adamsen Sven, Wøjdemann Morten, Møller Ann Merete
Department of Anaesthesiology and Intensive Care Medicine, Copenhagen University Hospital Herlev, Herlev Ringvej 75, DK-2730 Herlev, Denmark.
Scand J Gastroenterol. 2009;44(1):15-22. doi: 10.1080/00365520802307997.
Despite the introduction of histamine H2-receptor antagonists, proton-pump inhibitors and the discovery of Helicobacter pylori, both the incidence of emergency surgery for perforated peptic ulcer and the mortality rate for patients undergoing surgery for peptic ulcer perforation have increased. This increase has occurred despite improvements in perioperative treatment and monitoring. To improve the outcome of these patients, it is necessary to investigate the reasons behind this high mortality rate. In this review we evaluate the existing evidence in order to identify significant risk factors with an emphasis on risks that are preventable. A systematic review including randomized studies was carried out. There are a limited number of studies of patients with peptic ulcer perforation. Most of these studies are of low evident status. Only a few randomized, controlled trials have been published. The mortality rate and the extent of postoperative complications are fairly high but the reasons for this have not been thoroughly explained, even though a number of risk factors have been identified. Some of these risk factors can be explained by the septic state of the patient on admission. In order to improve the outcome of patients with peptic ulcer perforation, sepsis needs to be factored into the existing knowledge and treatment.
尽管引入了组胺H2受体拮抗剂、质子泵抑制剂并发现了幽门螺杆菌,但消化性溃疡穿孔的急诊手术发生率以及接受消化性溃疡穿孔手术患者的死亡率均有所上升。尽管围手术期治疗和监测有所改善,但这种上升仍在发生。为改善这些患者的治疗结果,有必要调查这种高死亡率背后的原因。在本综述中,我们评估现有证据,以确定显著的风险因素,重点关注可预防的风险。我们进行了一项包括随机研究的系统综述。关于消化性溃疡穿孔患者的研究数量有限。这些研究大多证据等级较低。仅发表了少数随机对照试验。死亡率和术后并发症的程度相当高,尽管已经确定了一些风险因素,但其原因尚未得到充分解释。其中一些风险因素可以用患者入院时的感染状态来解释。为改善消化性溃疡穿孔患者的治疗结果,需要将感染因素纳入现有知识和治疗中。